Henry Ji
Shugaba, Shugaba da Shugaba
- 25+ shekaru na gwaninta a cikin fasahar kere-kere da masana'antar kimiyyar rayuwa
- Dokta Ji ya kafa Sorrento kuma ya kasance darekta tun 2006, Shugaba da Shugaba tun 2012, kuma Shugaba tun 2017.
- A lokacin da yake aiki a Sorrento, ya ƙware kuma ya jagoranci babban ci gaban Sorrento ta hanyar saye da haɗewa ciki har da Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Debelopment Lymive Health, da Sorry Animal Health Systems, da Sorrento.
- Ya yi aiki a matsayin Babban Jami'in Kimiyya na Sorrento daga 2008 zuwa 2012 kuma a matsayin Shugaba na riko daga 2011 zuwa 2012
- Kafin Sorrento, ya rike manyan mukamai a CombiMatrix, Stratagene sannan kuma ya kafa Stratagene Genomics, reshen Stratagene, kuma ya yi aiki a matsayin Shugaba & Shugaba da Daraktan Hukumar.
- BS da Ph.D.
Rufe X
Dorman Followwill
Director
- Mista Followwill, ya kasance darakta tun Satumba 2017
- Ya kasance Babban Abokin Hulɗa, Lafiya na Canji a Frost & Sullivan, kamfani mai ba da shawara kan kasuwanci da ke cikin bincike da bincike na kasuwa, tuntuɓar dabarun haɓaka da horar da kamfanoni a cikin masana'antu da yawa, tun daga 2016.
- Kafin wannan lokacin, ya yi aiki a wurare daban-daban a Frost & Sullivan, ciki har da Abokin Hulɗa na Kwamitin Gudanarwa wanda ke kula da P & L na kasuwanci a Turai, Isra'ila da Afirka, da Abokin Hulɗa da ke kula da Harkokin Kiwon Lafiya da Rayuwa a Arewacin Amirka, tun lokacin da ya fara shiga. Frost & Sullivan don taimakawa sami aikin tuntuɓar a cikin Janairu 1988
- Mista Followwill yana da fiye da shekaru 30 na jagorancin ƙungiyoyi da ƙwarewar shawarwari na gudanarwa, wanda ya yi aiki a kan daruruwan ayyukan shawarwari a duk manyan yankuna da kuma sassan masana'antu da yawa, kowane aikin ya mayar da hankali kan mahimmancin mahimmanci na ci gaba.
- BA
Rufe X
Kim D. Janda
Director
- Dr. Janda ta yi aiki a matsayin darakta tun Afrilu 2012
- Dr. Janda ya kasance Ely R. Callaway, Jr. Shugaban Farfesa a Sashen Chemistry, Immunology da Microbial Science a Cibiyar Nazarin Scripps ("TSRI") tun 1996 kuma a matsayin darektan Cibiyar Bincike da Magunguna ta Worm ( "WIRM") a TSRI tun daga 2005. Bugu da ƙari, Dr. Janda ya yi aiki a matsayin Skaggs Scholar a cikin Skaggs Institute of Chemical Biology, kuma a TSRI, tun 1996.
- Ya buga fiye da 425 na asali wallafe-wallafe a cikin mujallolin da aka bita na tsara kuma ya kafa kamfanonin fasahar kere-kere CombiChem, Drug Abuse Sciences da AIPartia Dr. Janda abokin edita ne na "Bioorganic & Medicinal Chemistry", "PLoS ONE" kuma yana hidima, ko ya yi hidima. , akan allunan edita na mujallu masu yawa ciki har da J. Comb. Chem., Chem. Reviews, J. Med. Chem., Jaridar Botulinum, Bioorg. & Med. Chem. Lett., da Bioorg. & Med. Chem
- A cikin aiki na fiye da shekaru 25, Dr. Janda ya ba da gudummawa da yawa na seminal kuma ana ɗaukarsa ɗaya daga cikin masana kimiyya na farko don haɗa hanyoyin sinadarai da nazarin halittu a cikin shirin bincike na haɗin gwiwa.
- Dr. Janda ya yi aiki a kan Kwamitin Ba da Shawarwari na Kimiyya na Materia da Ma'aikatar Ilimi ta Singapore
- BS da Ph.D.
Rufe X
David Lemus
Director
- Mista Lemus ya yi aiki a matsayin darektan Kamfani tun Satumba 2017
- A halin yanzu shi ne Shugaba na Ironshore Pharmaceuticals, Inc.
- Bugu da ƙari yana aiki a matsayin memba mara zartarwa na Silence Therapeutics (NASDAQ: SLN) da BioHealth Innovation, Inc.
- A baya a Sigma Tau Pharmaceuticals, Inc. daga 2011-2015, ya yi aiki a matsayin Shugaba.
- Bugu da ƙari, Mista Lemus ya yi aiki a matsayin CFO da Babban Mataimakin Shugaban Kamfanin MorphoSys AG daga 1998-2011, yana ɗaukar jama'a ga jama'a a IPO na farko na ilimin halittu na Jamus.
- Kafin aikinsa a MorphoSys AG, ya rike mukamai daban-daban na gudanarwa ciki har da kamfanonin Hoffman La Roche, Electrolux AB, da Lindt & Spruengli AG (Ma'aji na Group)
- BS, MS, MBA, CPA
Rufe X
Jaisim Shah
Director
- Mr. Shah ya kasance darakta tun 2013
- 25+ shekaru na gwaninta a cikin masana'antar harhada magunguna
- A halin yanzu Mr. Shah yana aiki a matsayin Shugaba kuma Shugaban Kamfanin Scilex Holding da Scilex Pharmaceutical
- Kafin Scilex, ya yi aiki a matsayin Shugaba da Shugaban Semnur Pharmaceuticals (wanda Scilex Pharmaceuticals ya samu) tun farkonsa a 2013.
- Daga 2011 zuwa 2012, ya yi aiki a matsayin Babban Jami'in Harkokin Kasuwanci na Elevation Pharmaceuticals inda ya mayar da hankali kan kudi, hadewa da saye, da bunkasa kasuwanci.
- Kafin hawan, Mr. Shah ya kasance shugaban Zelos Therapeutics, inda ya mayar da hankali kan samar da kudade da bunkasa kasuwanci.
- Kafin Zelos, Mr. Shah shine Babban Mataimakin Shugaban kasa kuma Babban Jami'in Harkokin Kasuwanci a CytRx. A baya can, Mr. Shah ya kasance Babban Jami'in Kasuwanci a Facet Biotech da PDL BioPharma inda ya kammala yawan lasisi / haɗin gwiwa da ma'amaloli masu mahimmanci.
- Kafin PDL, Mr. Shah ya kasance VP na Kasuwancin Duniya a BMS inda ya sami "Kyawun Shugabanci" don kammala ɗaya daga cikin manyan haɗin gwiwar a tarihin kamfanin.
- MA dan MBA
Rufe X
Yau Alexander Wu
Director
- Dr. Wu ya kasance darakta tun watan Agusta 2016
- A halin yanzu kuma yana aiki akan BOD na Scilex Pharmaceutical tun 2019
- Dokta Wu shi ne wanda ya kafa, Shugaba, Shugaba, kuma Babban Jami'in Kimiyya na Crown Bioscience International, babban kamfanin gano magunguna da samar da hanyoyin samar da magunguna a duniya, wanda ya kafa a 2006.
- Daga 2004 zuwa 2006, ya kasance babban jami'in kasuwanci na Starvax International Inc. a birnin Beijing na kasar Sin, kamfanin fasahar kere-kere da ke mai da hankali kan ilmin halitta da cututtuka masu yaduwa.
- Daga 2001 zuwa 2004, ya kasance ma'aikacin banki tare da Burrill & Company inda ya kasance shugaban Ayyukan Asiya.
- BS, MS, MBA, da kuma Ph.D.
Rufe X